Dake Benjamin T's Form 4 filing
Jade Biosciences, Inc. (JBIO) · filed Oct 11, 2022
- Accession no.
- 0001415889-22-010429
- Filed
- Oct 11, 2022
- Trade date
- Oct 6-7, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions and 5 derivative transactions. Open-market sales total $374.7K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dake Benjamin TCIK 0001869248 | Officer (SEE REMARKS) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2022 | Common Stock | MOption exerciseAcquired | +2,411 | $1.74 | +$4,195.14 | 2,411 | Direct | |
| Oct 6, 2022 | Common Stock | MOption exerciseAcquired | +10,629 | $2.14 | +$22,746.06 | 13,040 | Direct | |
| Oct 6, 2022 | Common Stock | SSaleDisposed | −11,210 | $15.64F2 | −$175,324.4 | 1,830 | Direct | |
| Oct 6, 2022 | Common Stock | SSaleDisposed | −882 | $16.54F3 | −$14,588.28 | 948 | Direct | |
| Oct 6, 2022 | Common Stock | SSaleDisposed | −948 | $17.31F4 | −$16,409.88 | 0 | Direct | |
| Oct 7, 2022 | Common Stock | MOption exerciseAcquired | +10,520 | $2.14 | +$22,512.8 | 10,520 | Direct | |
| Oct 7, 2022 | Common Stock | SSaleDisposed | −8,763 | $15.93F5 | −$139,594.59 | 1,757 | Direct | |
| Oct 7, 2022 | Common Stock | SSaleDisposed | −1,757 | $16.41F6 | −$28,832.37 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2022 | Common Stock | MOption exerciseDisposed | −905 | $0.00 | $0 | 13,583 | Direct | |
| Oct 6, 2022 | Common Stock | MOption exerciseDisposed | −1,506 | $0.00 | $0 | 33,150 | Direct | |
| Oct 6, 2022 | Common Stock | MOption exerciseDisposed | −6,348 | $0.00 | $0 | 30,552 | Direct | |
| Oct 6, 2022 | Common Stock | MOption exerciseDisposed | −4,281 | $0.00 | $0 | 324,640 | Direct | |
| Oct 7, 2022 | Common Stock | MOption exerciseDisposed | −10,520 | $0.00 | $0 | 314,120 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.095 to $16.075, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $15.33 to $16.33, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
- F6
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $16.34 to $16.52, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.
Remarks
Officer Title: President, Chief Operating Officer and Secretary